CluePoints, a Cambridge, Mass.-based software provider of risk-based monitoring (RBM) solutions for clinical trials, has partnered with Bracket Global, a provider of technologies and services that drive superior clinical outcome results. The exclusive partnership will see CluePoints’ RBM software offered in combination with Bracket’s Blinded Data Analytics and Rater Training and Quality Assurance oversight program for psychiatry and neurology trials. Bringing together CluePoints’ and Bracket’s solutions will enhance the impact of the services that each company delivers to sponsors, improving the integrity and quality of clinical data.

Bracket Global Senior Vice President and Chief Medical Officer David Daniel said, “Integrating CluePoints’ software into Bracket’s Electronic Clinical Outcomes Assessment-based data quality monitoring programs provides a level of efficiency and sophistication in de-risking CNS studies that has not previously been possible.”